Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lucid Diagnostics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LUCD.
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: LENSAR (NASDAQ:LNSR), Baird Medical Investment (NASDAQ:BDMD), Sight Sciences (NASDAQ:SGHT), Odysight ai (NASDAQ:ODYS) and Vivani Medical (NASDAQ:VANI).
Lucid Diagnostics has a consensus price target of $3.75.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $1.18 last updated April 11, 2025 at 7:56 PM EDT.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.